Sanofi to expand immunology offerings with Blueprint Medicines

Sanofi has signed an agreement to acquire US-based Blueprint Medicines to bolster its immunology pipeline with rare disease treatments.

Jun 3, 2025 - 06:00
Sanofi to expand immunology offerings with Blueprint Medicines
Sanofi has signed an agreement to acquire US-based Blueprint Medicines to bolster its immunology pipeline with rare disease treatments.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow